Familial Mediterranean fever gene (MEFV) mutations as a modifier of systemic lupus erythematosus

Lupus

Volumn 21, Issue 9, 2012, Pages 993-998

  Shinar, Y ^a   Kosach, E ^b   Langevitz, P ^b,c   Zandman Goddard, G ^c,d   Pauzner, R ^b,c   Rabinovich, E ^b   Livneh, A ^b,c   Lidar, M ^b,c  

^a HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d WOLFSON MEDICAL CENTER   (Israel)

Author keywords

disease modification; FMF; lupus; MEFV; mutations

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FAMILIAL MEDITERRANEAN FEVER; FAMILIAL MEDITERRANEAN FEVER GENE; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOSPHOLIPID ANTIBODY SYNDROME; PRIORITY JOURNAL; SCORING SYSTEM; SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HETEROZYGOTE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MUTATION;

EID: 84863954703     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312441048     Document Type: Article

References (22)

1. Crispin JC Rheumatology. 5 th edn. Philadelphia: Mosby-Elsevier; 2011. p. 1289-1294. Hochberg M, ed. Philadelphia: Mosby-Elsevier ; 2011: 1289-1294.
2. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277 (Pubitemid 13221242)
3. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997 ; 40: 1879-1885 (Pubitemid 27452541)
4. Touitou I, Kone-Paut I. Autoinflammatory diseases. Best Pract Res Clin Rheumatol. 2008 ; 22: 811-829
5. Lachmann HJ, Sengul B, Yavuzsen TU, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 2006; 45: 746-750. (Pubitemid 43985345)
6. Kogan A, Shinar Y, Lidar M, et al. Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet. 2001 ; 102: 272-276 (Pubitemid 32730278)
7. Rabinovich E, Livneh A, Langevitz P, et al. Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis. 2005 ; 64: 1009-1014 (Pubitemid 40909514)
8. Fidder H, Chowers Y, Ackerman Z, et al. The familial Mediterranean fever (MEVF) gene as a modifier of Crohn's disease. Am J Gastroenterol. 2005 ; 100: 338-343 (Pubitemid 40314518)
9. Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A. Behcet's disease in familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum. 2000 ; 29: 286-295 (Pubitemid 30235980)
10. Shinar Y, Livneh A, Villa Y, et al. Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients. Genes Immun. 2003 ; 4: 197-203 (Pubitemid 38967597)
11. Padeh S, Stoffman N, Berkun Y. Periodic fever accompanied by aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA syndrome) in adults. Isr Med Assoc J. 2008 ; 10: 358-360 (Pubitemid 351902935)
12. Lidar M, Zandman-Goddard G, Shinar Y, Zaks N, Livneh A, Langevitz P. Systemic lupus erythematosus and familial Mediterranean fever: a possible negative association between the two disease entities-report of four cases and review of the literature. Lupus. 2008 ; 17: 663-669
13. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
14. Gladman DD, Urowitz MB, Goldsmith CH, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 809-813 (Pubitemid 27199995)
15. Livneh A, Langevitz P, Shinar Y, et al. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid. 1999 ; 6: 1-6 (Pubitemid 29249929)
16. Rozenbaum M, Rosner I. Severe outcome of juvenile idiopathic arthritis (JIA) associated with familial Mediterranean fever (FMF). Clin Exp Rheumatol. 2004 ; 22: S75 - S78
17. Cazeneuve C, Hovannesyan Z, Genevieve D, et al. Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations. Arthritis Rheum. 2003 ; 48: 2324-2331 (Pubitemid 36959215)
18. Cazeneuve C, Sarkisian T, Pecheux C, et al. MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet. 1999 ; 65: 88-97 (Pubitemid 30470452)
19. Yung S, Chan TM. Anti-DNA antibodies in the pathogenesis of lupus nephritis-the emerging mechanisms. Autoimmun Rev. 2008 ; 7: 317-321
20. Zandman-Goddard G, Blank M, Langevitz P, et al. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Ann Rheum Dis. 2005 ; 64: 1698-1702 (Pubitemid 41667142)
21. Ozen S, Bakkaloglu A. C reactive protein: protecting from lupus in familial Mediterranean fever. Ann Rheum Dis. 2005 ; 64: 786-787 (Pubitemid 40559314)
22. Stoffman N, Magal N, Shohat T, et al. Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups. Eur J Hum Genet. 2000 ; 8: 307-310 (Pubitemid 30336185)